Research led by the University of Warwick, along with researchers from  Ninewells Hospital Dundee, and the University of Edinburgh, have found a  new light-activated platinum-based compound that is up to 80 times more  powerful than other platinum-based anti-cancer drugs and which can use  “light activation” to kill cancer cells in a much more targeted way than  similar treatments. 
The University of Warwick team had already found a platinum-based  compound that they could activate with ultra-violet light but that  narrow wave length of light would have limited its use. Their latest  breakthrough has discovered a new platinum based compound known as trans,trans,trans-[Pt(N3)2(OH)2(py)2] (see structure)  that can be activated by normal visible blue, or even green, light. It  is also stable and easy to work with, and it is water soluble so it can  simply dissolve and be flushed out of the body after use. Tests show that once activated by blue light the compound was highly  effective requiring a concentration of just 8.4 micro moles per litre to  kill 50% of the cancer cells. The researchers are also beginning to  examine the compound’s effectiveness against ovarian and liver cancer  cells. Early results there are also excellent but that testing work is  not yet complete.
“This compound could have a significant impact on the effectiveness of future cancer treatments. Light activation provides this compound’s massive toxic power and also allows treatment to be targeted much more accurately against cancer cells...claims Prof. Peter Sadler...
Ref : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2980786/
